Allergan Aesthetics received FDA approval for Skinvive by Juvéderm for the improvement of neck appearance, marking the first and only FDA-cleared hyaluronic acid injectable indicated for neck lines and skin quality in that region. The product uses Juvéderm's proprietary crosslinking technology and is positioned as a skin-quality treatment rather than a pure volumizer — a clinical distinction that matters for patient consultation and reimbursement coding.
Injectables
FDA Approves Skinvive by Juvéderm for Neck Appearance — What the Indication Means for Your Juvéderm Mix
Allergan's newest indication expands the Juvéderm portfolio beyond facial volume; practices now have an FDA-cleared injectable specifically for neck lines and skin quality.
1-YEAR MOVE
ABBV
▲11.6%
| Ticker | Company | 1-year change |
|---|---|---|
| ABBV | AbbVie (Allergan Aesthetics) | +11.6% |
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Skinvive is the first and only FDA-cleared injectable indicated specifically for neck appearance.
For practices already on the Allē loyalty program, Skinvive represents a new revenue stream in a high-margin category. Neck treatments command premium pricing (typically $600–$900 per syringe in most markets) and drive repeat business; patients seeking neck improvement often return for maintenance every 6–9 months. The approval also signals Allergan's strategy to own the "skin quality" narrative across the face and now the neck, competing directly against Galderma's Restylane range and Revance's RHA line in the dynamic-filler space.
Source: original report ↗
Frequently asked questions
What is Skinvive by Juvéderm FDA approved for?
Skinvive by Juvéderm is FDA-approved for the improvement of neck appearance, specifically targeting neck lines and skin quality. It is the first and only FDA-cleared hyaluronic acid injectable with an indication specifically for the neck region.
How often do patients need Skinvive neck treatments?
Patients typically return for Skinvive maintenance every 6–9 months. This repeat-visit schedule creates a predictable revenue cycle for practices offering the treatment.
What is the typical pricing for Skinvive neck injections?
Skinvive neck treatments typically command $600–$900 per syringe in most markets, positioning it as a high-margin service for aesthetic practices.
Is Skinvive a volumizer or a skin quality treatment?
Skinvive is positioned as a skin-quality treatment rather than a pure volumizer. This clinical distinction is important for patient consultation and affects how the treatment is coded and explained to patients.
How does Skinvive compete with other neck injectables?
Skinvive uses Juvéderm's proprietary crosslinking technology and competes directly against Galderma's Restylane range and Revance's RHA line in the dynamic-filler space, as part of Allergan's broader strategy to own the skin-quality narrative.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.